FIELD: medicine.
SUBSTANCE: invention relates to field of biotechnology, virology and medicine. Described is immunogenic composition of preliminarily determined inactivated strains of human immunodeficiency virus (HIV). Inactivation is carried out by means of psoralen and ultrasonic radiation. Composition is made more efficient by removal of structural HIV peculiarities, which prevent immune response. In particular, sialic acid is removed in order to enhance immune recognition of composition and for weakening of complimentary H factor binding. Also for prevention of complimentary H factor binding CD55 and CD59 are removed. Determination of strains for inactivation can be realised by means of immunotherapeutic genotyping or probabilistic assessment of infection risk.
EFFECT: invention can be used in medicine.
30 cl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOGENIC COMPOSITION AND METHOD OF FUSED PROTEIN VACCINE DEVELOPMENT | 2004 |
|
RU2407749C2 |
| IMMUNOGENIC COMPOSITION BASED ON CONDITIONALLY LIVE VIRION AND METHOD FOR MAKING THEREOF | 2006 |
|
RU2415933C2 |
| IMMUNOGENIC COMPOSITION AND METHOD FOR DESIGNING VACCINE BASED ON H-FACTOR BINDING SITES | 2004 |
|
RU2364413C2 |
| IMMUNOGENIC COMPOSITION AND METHOD OF DEVELOPMENT OF VACCINE BASED ON HIV MATRIX PROTEIN REGIONS | 2004 |
|
RU2403915C2 |
| EFFECTIVE INFLUENZA VLPS | 2004 |
|
RU2369405C2 |
| SYSTEMS FOR EXPRESSION OF NEWCASTLE DISEASE VIRUS RECOMBINANT RNA AND VACCINES | 1999 |
|
RU2270864C2 |
| RECOMBINANT INFLUENZA VIRUS A | 2001 |
|
RU2280690C2 |
| FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPs) | 2006 |
|
RU2483751C2 |
| VIRUS-LIKE PARTICLES WITH HIGH-DENSITY COATING FOR INDUCTION OF ANTIBODY EXPRESSION | 2017 |
|
RU2813282C2 |
| VACCINE AGAINST HIV/AIDS | 2010 |
|
RU2475264C2 |
